Armetheon
web.archive.orgArmetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company. In Q3, 2017, Armetheon merged with Espero Pharmaceuticals, Inc to become Espero BioPharma, Inc, a commercial-stage cardiovascular-focused company with 3 marketed products and a potential blockbuster pipeline. [www.esperobio.com]
Read more
Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company. In Q3, 2017, Armetheon merged with Espero Pharmaceuticals, Inc to become Espero BioPharma, Inc, a commercial-stage cardiovascular-focused company with 3 marketed products and a potential blockbuster pipeline. [www.esperobio.com]
Read more
Country
State
California
City (Headquarters)
Santa Clara
Industry
Employees
11-50
Founded
2011
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Clinical Trial Specialist
Email ****** @****.comPhone (***) ****-****
Technologies
(418)
Reach decision makers at Armetheon
Free credits every month!
Armetheon FAQ
Santa Clara, United States
Pharmaceutical Manufacturing
